NeoGenomics stockholders approve 5M share increase to 2023 equity plan, elect all director nominees

NEOGENOMICS INC

All nine director nominees elected; Lynn Tetrault received 105.7M votes for (96.9% of votes cast).
Advisory say-on-pay passed with 83.19% of votes cast in favor.
Amendment to 2023 equity plan increasing authorized shares by 5,000,000 approved with 97.9% of votes cast.
Ratification of Deloitte as independent auditor approved with 99.57% of votes cast.

item 5.02 item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001628280-26-037735
form_type: 8-K
ticker: NEO
cik: 0001077183
company_name: NEOGENOMICS INC
filed_at: 2026-05-22T20:19:44+00:00
discovered_at: 2026-05-22T20:21:00.210399+00:00
generated_at: 2026-05-22T20:55:22.000643+00:00
sec_items: ["5.02", "5.07", "9.01"]
event_type: other
sentiment: neutral
materiality_score: 0.3
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001628280-26-037735
json_url: https://secwatch.observer/filing/0001628280-26-037735.json
markdown_url: https://secwatch.observer/filing/0001628280-26-037735.md
text_url: https://secwatch.observer/filing/0001628280-26-037735.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1077183/000162828026037735/0001628280-26-037735-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1077183/000162828026037735/neo-20260521.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001628280-26-037735

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.